Northern Trust Corp Arbutus Biopharma Corp Transaction History
Northern Trust Corp
- $658 Billion
- Q1 2025
A detailed history of Northern Trust Corp transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Northern Trust Corp holds 1,283,601 shares of ABUS stock, worth $4.36 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,283,601
Previous 1,330,683
3.54%
Holding current value
$4.36 Million
Previous $4.35 Million
2.94%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding ABUS
# of Institutions
191Shares Held
111MCall Options Held
866KPut Options Held
608K-
Morgan Stanley New York, NY23.8MShares$80.9 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY13.3MShares$45.2 Million27.3% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$39.3 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY9.47MShares$32.2 Million1.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.95MShares$30.4 Million0.0% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $510M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...